Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
Periyannan VeluAnnamalai VijayalakshmiVeerasamy VinothkumarPublished in: The Journal of pharmacy and pharmacology (2020)
Therefore, addition of SRA to SCC131 cells may provide a promising natural therapeutic strategy against squamous cell carcinomas with potential application in clinical analysis.